Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Optimising social mixing strategies achieving COVID-19 herd immunity while minimising mortality in six European countries

Romain Ragonnet, Guillaume Briffoteaux, Bridget M. Williams, Julian Savulescu, Matthew Segal, Milinda Abayawardana, View ORCID ProfileRosalind M. Eggo, Daniel Tuyttens, Nouredine Melab, View ORCID ProfileBen J. Marais, Emma S. McBryde, James M. Trauer
doi: https://doi.org/10.1101/2020.08.25.20182162
Romain Ragonnet
1School of Public Health and Preventive Medicine, Monash University, Melbourne VIC 3004, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: romain.ragonnet@monash.edu
Guillaume Briffoteaux
2Mathematics and Operational Research Department, University of Mons, 7000 Mons, Belgium
3CNRS CRIStAL, Inria Lille, Université de Lille, 59000 Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bridget M. Williams
1School of Public Health and Preventive Medicine, Monash University, Melbourne VIC 3004, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julian Savulescu
4Murdoch Children’s Research Institute, Parkville VIC 3065, Australia
5Uehiro Centre for Practical Ethics, University of Oxford, Oxford OX1 1PT, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Segal
1School of Public Health and Preventive Medicine, Monash University, Melbourne VIC 3004, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Milinda Abayawardana
1School of Public Health and Preventive Medicine, Monash University, Melbourne VIC 3004, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosalind M. Eggo
6Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rosalind M. Eggo
Daniel Tuyttens
2Mathematics and Operational Research Department, University of Mons, 7000 Mons, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nouredine Melab
3CNRS CRIStAL, Inria Lille, Université de Lille, 59000 Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ben J. Marais
7Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Westmead NSW 2145, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ben J. Marais
Emma S. McBryde
8Australian Institute of Tropical Health and Medicine, James Cook University, Douglas QLD 4814, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James M. Trauer
1School of Public Health and Preventive Medicine, Monash University, Melbourne VIC 3004, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Strategies are needed to minimise the impact of COVID-19 in the medium-to-long term, until safe and effective vaccines can be used. Using a mathematical model in a formal optimisation framework, we identified contact mitigation strategies that minimised COVID-19-related mortality over a time-horizon of 15 months while achieving herd immunity in six or 12 months, in Belgium, France, Italy, Spain, Sweden, and the UK. We show that manipulation of social contacts by age can reduce the impact of COVID-19 considerably in the presence of intense transmission. If immunity was persistent, the optimised scenarios would result in herd immunity while causing a number of deaths considerably lower than that observed during the March-April European wave in Belgium, France, Spain and Sweden, whereas the numbers of deaths required to achieve herd immunity would be comparable to somewhat larger that the past epidemics in Italy and the UK. Our results also suggest that countries’ herd immunity thresholds may be considerably lower than first estimated for SARS-CoV-2. If post-infection immunity was short-lived, ongoing contact mitigation would be required to prevent major epidemic resurgence.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

RR was supported by a Project Grant (APP1144570) from the Australian National Health and Medical Research Council. JMT was supported by an Early Career Fellowship (APP1142638) from the Australian National Health and Medical Research Council.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Not applicable

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Revised version of the manuscript after addressing reviewers' comments.

Data Availability

The study was conducted using publically available data only. The references are presented in the manuscript.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 18, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Optimising social mixing strategies achieving COVID-19 herd immunity while minimising mortality in six European countries
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Optimising social mixing strategies achieving COVID-19 herd immunity while minimising mortality in six European countries
Romain Ragonnet, Guillaume Briffoteaux, Bridget M. Williams, Julian Savulescu, Matthew Segal, Milinda Abayawardana, Rosalind M. Eggo, Daniel Tuyttens, Nouredine Melab, Ben J. Marais, Emma S. McBryde, James M. Trauer
medRxiv 2020.08.25.20182162; doi: https://doi.org/10.1101/2020.08.25.20182162
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Optimising social mixing strategies achieving COVID-19 herd immunity while minimising mortality in six European countries
Romain Ragonnet, Guillaume Briffoteaux, Bridget M. Williams, Julian Savulescu, Matthew Segal, Milinda Abayawardana, Rosalind M. Eggo, Daniel Tuyttens, Nouredine Melab, Ben J. Marais, Emma S. McBryde, James M. Trauer
medRxiv 2020.08.25.20182162; doi: https://doi.org/10.1101/2020.08.25.20182162

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (238)
  • Allergy and Immunology (521)
  • Anesthesia (124)
  • Cardiovascular Medicine (1417)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (291)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (582)
  • Epidemiology (10286)
  • Forensic Medicine (6)
  • Gastroenterology (527)
  • Genetic and Genomic Medicine (2625)
  • Geriatric Medicine (254)
  • Health Economics (496)
  • Health Informatics (1729)
  • Health Policy (789)
  • Health Systems and Quality Improvement (671)
  • Hematology (266)
  • HIV/AIDS (564)
  • Infectious Diseases (except HIV/AIDS) (12083)
  • Intensive Care and Critical Care Medicine (648)
  • Medical Education (273)
  • Medical Ethics (83)
  • Nephrology (288)
  • Neurology (2455)
  • Nursing (144)
  • Nutrition (377)
  • Obstetrics and Gynecology (490)
  • Occupational and Environmental Health (566)
  • Oncology (1318)
  • Ophthalmology (400)
  • Orthopedics (146)
  • Otolaryngology (235)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (342)
  • Pediatrics (778)
  • Pharmacology and Therapeutics (329)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2394)
  • Public and Global Health (4998)
  • Radiology and Imaging (892)
  • Rehabilitation Medicine and Physical Therapy (525)
  • Respiratory Medicine (681)
  • Rheumatology (309)
  • Sexual and Reproductive Health (255)
  • Sports Medicine (244)
  • Surgery (297)
  • Toxicology (45)
  • Transplantation (140)
  • Urology (108)